ROCHE FARMA, S.A. won Spain – Pharmaceutical products – Suministro del medicamento exclusivo Emicizumab (HEMLIBRA) from Servicio Madrileno de Salud, Hospital Universitario La Paz

Servicio Madrileno de Salud, Hospital Universitario La Paz · Spain government award

GlobalGov surfaces government contract awards from around the world, including the markets your competitors overlook.

$3.4M
Award Value
November 4, 2024
Award Date
Awarded
Status

Award Overview

ROCHE FARMA, S.A. was awarded Spain – Pharmaceutical products – Suministro del medicamento exclusivo Emicizumab (HEMLIBRA) by Servicio Madrileno de Salud, Hospital Universitario La Paz in Spain, tracked by GlobalGov. The award is valued at $3.4M. It was awarded on November 4, 2024. Full award details and the issuing agency are below.

See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.

Start Free

Award Details

AwardeeROCHE FARMA, S.A.
Awardee countrySpain
Awarding agencyServicio Madrileno de Salud, Hospital Universitario La Paz
CountrySpain
Award value$3.4M
Award dateNovember 4, 2024
Last verifiedSeptember 1, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Track every Spain contract award and the opportunities behind them. Free for 14 days.

Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required